DiaMedica Therapeutics Inc. (DMAC) vs NeuroPace, Inc. (NPCE)
A side-by-side comparison of DiaMedica Therapeutics Inc. and NeuroPace, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DMAC
DiaMedica Therapeutics Inc.
$8.13HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
NPCE
NeuroPace, Inc.
$12.67HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — DMAC vs NPCE
growth of $100 · dividends reinvested · last 5yDMAC -10.6% (-2.2%/yr)NPCE -47.0% (-11.9%/yr)DMAC compounded faster over this window
DMAC NPCE
DMAC vs NPCE: by the numbers
- •DMAC is the larger company ($438M vs $432M market cap).
- •Both run net losses; DMAC's is the smaller (0.00% vs -19.34% net margin).
Metrics side by side
Valuation
| Metric | DMAC | NPCE |
|---|---|---|
| P/S ratio | N/A | 4.37 |
| P/B ratio | 11.43 | 36.35 |
Profitability
| Metric | DMAC | NPCE |
|---|---|---|
| Gross margin | 0.00% | 79.63% |
| Operating margin | 0.00% | -15.26% |
| Net margin | 0.00% | -19.34% |
| ROE | -97.92% | -160.85% |
| ROIC | -100.87% | -18.95% |
Growth (annualized)
| Metric | DMAC | NPCE |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 15.85% |
| Total return CAGR (5Y) | 16.41% | -4.94% |
Frequently asked
- How have DMAC and NPCE total returns compared?
- Over the past 5 years, DMAC delivered 16.41% and NPCE delivered -4.94% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
DiaMedica Therapeutics ROENeuroPace ROEDiaMedica Therapeutics operating marginNeuroPace operating marginDiaMedica Therapeutics revenue growthNeuroPace revenue growthDiaMedica Therapeutics free cash flowNeuroPace free cash flow
DiaMedica Therapeutics & NeuroPace appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.